Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012911 |
---|---|
Receipt number | R000015081 |
Scientific Title | Program of vascular evaluation under uric acid control by xanthine oxidase inhibitor , febuxostat : multicenter , randomized controlled study |
Date of disclosure of the study information | 2014/01/22 |
Last modified on | 2020/08/11 10:24:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/21 16:26:08 | ||
2 | Update | 2014/11/27 15:28:10 | Key exclusion criteria Key exclusion criteria |
|
3 | Update | 2014/11/27 15:29:43 | Institutions |
|
4 | Update | 2015/03/12 17:15:22 | Institutions |
|
5 | Update | 2015/06/09 15:21:58 | Key exclusion criteria |
|
6 | Update | 2015/08/21 10:30:18 | Institutions |
|
7 | Update | 2016/01/25 15:44:32 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information Institutions |
|
8 | Update | 2016/03/08 14:44:22 | Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2016/07/26 10:19:24 | Recruitment status Last follow-up date Date of closure to data entry |
|
10 | Update | 2018/08/01 11:20:11 | Organization Last name of contact person Last name of contact person Organization Division name Address Address TEL Name of person sending information Name of person sending information Division name Address Address TEL Name of primary person or sponsor Institute Organization Organization Co-sponsor Co-sponsor Email1 Institutions |
|
11 | Update | 2018/08/01 11:25:35 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
12 | Update | 2019/07/30 14:07:47 | Date of IRB Date trial data considered complete Date analysis concluded |
|
13 | Update | 2020/01/26 11:22:24 | Other related information Other related information |
|
14 | Update | 2020/08/11 10:23:28 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
15 | Update | 2020/08/11 10:24:31 | Recruitment status |
|
16 | Update | 2020/08/11 10:24:57 | Publication of results |